JP2012521406A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012521406A5 JP2012521406A5 JP2012501412A JP2012501412A JP2012521406A5 JP 2012521406 A5 JP2012521406 A5 JP 2012521406A5 JP 2012501412 A JP2012501412 A JP 2012501412A JP 2012501412 A JP2012501412 A JP 2012501412A JP 2012521406 A5 JP2012521406 A5 JP 2012521406A5
- Authority
- JP
- Japan
- Prior art keywords
- dioxo
- acetamide
- pyrimidin
- tetrahydrofuro
- thiazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN665MU2009 | 2009-03-23 | ||
| IN665/MUM/2009 | 2009-03-23 | ||
| US17135509P | 2009-04-21 | 2009-04-21 | |
| US61/171,355 | 2009-04-21 | ||
| IN2213MU2009 | 2009-09-23 | ||
| IN2213/MUM/2009 | 2009-09-23 | ||
| US25199409P | 2009-10-15 | 2009-10-15 | |
| US61/251,994 | 2009-10-15 | ||
| IN2906MU2009 | 2009-12-16 | ||
| IN2906/MUM/2009 | 2009-12-16 | ||
| US29447010P | 2010-01-12 | 2010-01-12 | |
| US61/294,470 | 2010-01-12 | ||
| PCT/IB2010/000840 WO2010109329A1 (en) | 2009-03-23 | 2010-03-22 | Furopyrimidinedione derivatives as trpa1 modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012521406A JP2012521406A (ja) | 2012-09-13 |
| JP2012521406A5 true JP2012521406A5 (enExample) | 2013-05-02 |
Family
ID=42780205
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012501412A Pending JP2012521406A (ja) | 2009-03-23 | 2010-03-22 | Ｔｒｐａ１調節因子としてのフロピリミジンジオン誘導体 |
| JP2012501414A Expired - Fee Related JP5612070B2 (ja) | 2009-03-23 | 2010-03-23 | Ｔｒｐａ１調節因子としてのチエノピリミジンジオン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012501414A Expired - Fee Related JP5612070B2 (ja) | 2009-03-23 | 2010-03-23 | Ｔｒｐａ１調節因子としてのチエノピリミジンジオン誘導体 |
Country Status (22)
| Country | Link |
|---|---|
| US (4) | US20120178766A1 (enExample) |
| EP (3) | EP2411395B1 (enExample) |
| JP (2) | JP2012521406A (enExample) |
| KR (2) | KR20110128898A (enExample) |
| CN (3) | CN102361874A (enExample) |
| AP (1) | AP2948A (enExample) |
| AU (2) | AU2010227225A1 (enExample) |
| BR (2) | BRPI1013705A2 (enExample) |
| CA (2) | CA2756535A1 (enExample) |
| DK (3) | DK2411395T3 (enExample) |
| EA (2) | EA201190138A1 (enExample) |
| ES (3) | ES2424341T3 (enExample) |
| HU (1) | HUE024538T2 (enExample) |
| IL (2) | IL215177A (enExample) |
| MX (1) | MX2011009822A (enExample) |
| PE (2) | PE20120834A1 (enExample) |
| PL (3) | PL2411395T3 (enExample) |
| PT (3) | PT2411395E (enExample) |
| SG (4) | SG174398A1 (enExample) |
| SI (3) | SI2411395T1 (enExample) |
| WO (2) | WO2010109329A1 (enExample) |
| ZA (2) | ZA201107650B (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2456515T3 (es) | 2009-03-23 | 2014-04-22 | Glenmark Pharmaceuticals S.A. | Derivados de pirimidindiona fusionados como moduladores de TRPA1 |
| PE20120834A1 (es) | 2009-03-23 | 2012-07-25 | Glenmark Pharmaceuticals Sa | Derivados de furopirimidindiona como moduladores de trpa1 |
| KR101591153B1 (ko) * | 2010-12-20 | 2016-02-02 | 그렌마크 파머수티칼스 에스. 아. | Trpa1 길항제로서의 2-아미노-4-아릴티아졸 화합물 |
| EP2520566A1 (en) | 2011-05-06 | 2012-11-07 | Orion Corporation | New Pharmaceutical Compounds |
| RU2014100744A (ru) * | 2011-06-13 | 2015-07-20 | Гленмарк Фармасьютикалс С.А. | Лечение респираторных нарушений с помощью trpa1 антагонистов |
| WO2012176105A1 (en) | 2011-06-22 | 2012-12-27 | Glenmark Pharmaceuticals Sa | Pharmaceutical composition comprising a trpa1 antagonist and a leukotriene receptor antagonist |
| JP2014517062A (ja) * | 2011-06-22 | 2014-07-17 | グレンマーク ファーマシューティカルズ， エセ．アー． | ＴＲＰＡ１アンタゴニスト及びβ２アゴニストを含む医薬組成物 |
| US20140148423A1 (en) * | 2011-07-25 | 2014-05-29 | Glenmark Pharmaceuticals S.A. | Pharmaceutical composition comprising a trpa1 antagonist and a steroid |
| US20140364445A1 (en) * | 2011-12-05 | 2014-12-11 | Glenmark Pharmaceuticals S.A. | Pharmaceutical composition comprising a trpa1 antagonist and an anticholinergic agent |
| AU2013273118B2 (en) * | 2012-06-08 | 2015-11-05 | Glenmark Pharmaceuticals S.A. | Amides of 2-amino-4-arylthiazole compounds and their salts |
| PE20150598A1 (es) | 2012-10-01 | 2015-05-20 | Orion Corp | Derivados de n-prop-2-inil carboxamida y su uso como antagonistas del receptor transitorio potencial de la subfamilia a, miembro 1 |
| WO2014203210A1 (en) * | 2013-06-20 | 2014-12-24 | Glenmark Pharmaceuticals S.A. | Nanoparticulate formulation comprising a trpa1 antagonist |
| MX2016004741A (es) | 2013-10-15 | 2016-07-26 | Glenmark Pharmaceuticals Sa | Composicion farmaceutica que comprende un antagonista de trpa1 y un agente analgesico. |
| EP3180345B1 (en) * | 2014-08-11 | 2018-10-10 | Hydra Biosciences, Inc. | Thieno- and furo[2,3-d]pyrimidine-2,4[1h,3h]-dione derivatives as trpc5 modulators for the treatment of neuropsychiatric disorders |
| JP6667092B2 (ja) * | 2014-08-11 | 2020-03-18 | ハイドラ・バイオサイエンシーズ・リミテッド・ライアビリティ・カンパニーＨｙｄｒａ Ｂｉｏｓｃｉｅｎｃｅｓ， ＬＬＣ | ピロロ［３，２−ｄ］ピリミジン−２，４（３Ｈ，５Ｈ）−ジオン誘導体 |
| EP3180337B1 (en) * | 2014-08-11 | 2018-10-10 | Hydra Biosciences, Inc. | Pyrido[3,4-d]pyrimidine-2,4(1h,3h)-dione derivatives |
| EP3180340B1 (en) * | 2014-08-11 | 2018-10-10 | Hydra Biosciences, Inc. | Pyrido[2,3-d]pyrimidine-2,4(1h,3h)-dione derivatives |
| WO2016028325A1 (en) | 2014-08-22 | 2016-02-25 | Duke University | Trpa1 and trpv4 inhibitors and methods of using the same for organ-specific inflammation and itch |
| WO2016042501A1 (en) | 2014-09-16 | 2016-03-24 | Glenmark Pharmaceuticals S.A. | Trpa1 antagonist for the treatment of pain associated to diabetic neuropathic pain |
| US11229628B2 (en) | 2015-01-09 | 2022-01-25 | Duke University | TRPA1 and TRPV4 inhibitors and methods of using the same for organ-specific inflammation and itch |
| WO2017060488A1 (en) | 2015-10-09 | 2017-04-13 | Almirall, S.A. | New trpa1 antagonists |
| WO2017064068A1 (en) | 2015-10-14 | 2017-04-20 | Almirall, S.A. | New trpa1 antagonists |
| CN109310683A (zh) | 2016-04-07 | 2019-02-05 | 杜克大学 | 用于消毒和麻醉的trpv4和trpa1的小分子双重抑制剂 |
| JP7178357B2 (ja) * | 2017-03-07 | 2022-11-25 | エフ．ホフマン－ラ ロシュ アーゲー | オキサジアゾール一過性受容器電位チャネル阻害剤 |
| CN109422749B (zh) * | 2017-08-21 | 2023-01-24 | 重庆医药工业研究院有限责任公司 | 一种抑制单羧酸转运蛋白的嘧啶二酮衍生物 |
| JP7612682B2 (ja) | 2019-10-15 | 2025-01-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規なテトラゾール |
| IL301717B2 (en) * | 2020-10-14 | 2026-05-01 | Boehringer Ingelheim Int | History of tetrazoles as TRPA1 inhibitors |
| KR20230087531A (ko) * | 2020-10-14 | 2023-06-16 | 베링거 인겔하임 인터내셔날 게엠베하 | Trpa1 억제제로서 테트라졸 유도체 |
| WO2022179469A1 (zh) * | 2021-02-23 | 2022-09-01 | 南京明德新药研发有限公司 | 噻吩并嘧啶二酮类化合物及其应用 |
| JP7565457B2 (ja) | 2021-04-14 | 2024-10-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ＴＲＰＡ１阻害剤としての３Ｈ，４Ｈ－チエノ－［２，３－ｄ］ピリミジン－４－オン誘導体 |
| CN114656480B (zh) * | 2022-04-27 | 2024-01-26 | 成都施贝康生物医药科技有限公司 | 噻吩并嘧啶类化合物、异构体或盐及其制备方法和用途 |
| CN114671875A (zh) * | 2022-04-27 | 2022-06-28 | 成都施贝康生物医药科技有限公司 | 新型二氢嘧啶类化合物、异构体或盐及其制备方法和用途 |
| WO2025264860A2 (en) | 2024-06-18 | 2025-12-26 | Yale University | Methods of treating post-covid airway disease |
| WO2026139068A1 (zh) * | 2024-12-26 | 2026-07-02 | 武汉朗来科技发展有限公司 | 作为trpa1抑制剂的化合物、其药物组合物和应用 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2248231A1 (de) | 1972-10-02 | 1974-04-11 | Basf Ag | 3-aminoisothiazolo eckige klammer auf 3,4-d eckige klammer zu pyrimidine |
| SE9701398D0 (sv) | 1997-04-15 | 1997-04-15 | Astra Pharma Prod | Novel compounds |
| SE9702001D0 (sv) * | 1997-05-28 | 1997-05-28 | Astra Pharma Prod | Novel compounds |
| US6300334B1 (en) * | 1998-08-28 | 2001-10-09 | Astrazeneca Ab | Thieno[2,3-d]pyrimidine-2,4-diones |
| ES2193839B1 (es) | 2001-06-22 | 2005-02-16 | Almirall Prodesfarma, S.A. | Nuevos derivados de 6-fenildihidropirrolpirimidindiona. |
| GB0118479D0 (en) * | 2001-07-28 | 2001-09-19 | Astrazeneca Ab | Novel compounds |
| AU2003253165A1 (en) * | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Pyrimidine fused bicyclic metalloproteinase inhibitors |
| AU2003288956A1 (en) * | 2002-10-30 | 2004-06-07 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of rock and other protein kinases |
| US6890923B2 (en) * | 2002-12-16 | 2005-05-10 | Astrazeneca Ab | Compounds |
| WO2004055054A1 (en) | 2002-12-18 | 2004-07-01 | Novartis Ag | Anktm1, a cold-activated trp-like channel expressed in nociceptive neurons |
| SE0300119D0 (sv) * | 2003-01-17 | 2003-01-17 | Astrazeneca Ab | Novel compounds |
| WO2005019188A1 (ja) | 2003-08-22 | 2005-03-03 | Takeda Pharmaceutical Company Limited | 縮合ピリミジン誘導体およびその用途 |
| EP1713815A4 (en) | 2004-02-11 | 2009-03-11 | Smithkline Beecham Corp | PTH AGONISTS |
| WO2005089206A2 (en) | 2004-03-13 | 2005-09-29 | Irm Llc | Modulators of ion channel trpa1 |
| JPWO2006083005A1 (ja) | 2005-02-03 | 2008-06-26 | 武田薬品工業株式会社 | 縮合ピリミジン誘導体およびその用途 |
| CA2617788A1 (en) * | 2005-08-04 | 2007-02-15 | Apogee Biotechnology Corporation | Sphingosine kinase inhibitors and methods of their use |
| DE602006014576D1 (de) * | 2005-11-08 | 2010-07-08 | Organon Nv | Zur behandlung von mit trpv1 in zusammenhang stehenden erkrankungen geeignete 2-(benzimidazol-1yl)-n-(4-phenylthiazol-2-yl)acetamidderivate |
| US20070105920A1 (en) * | 2005-11-08 | 2007-05-10 | Akzo Nobel N.V. | 2-(Benzimidazol-1-Yl)-N-(4-phenylthiazol-2-yl) acetamide derivatives |
| WO2007054480A1 (en) * | 2005-11-08 | 2007-05-18 | N.V. Organon | 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor |
| EP1962855B1 (en) * | 2005-12-22 | 2013-08-21 | Hydra Biosciences, Inc. | Trpa1 inhibitors for treating pain |
| TW200800997A (en) | 2006-03-22 | 2008-01-01 | Astrazeneca Ab | Chemical compounds |
| WO2008094909A2 (en) | 2007-01-29 | 2008-08-07 | Xenon Pharmaceuticals Inc. | Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions |
| WO2009002933A1 (en) * | 2007-06-22 | 2008-12-31 | Hydra Biosciences, Inc. | Methods and compositions for treating disorders |
| CN101711413B (zh) * | 2007-06-25 | 2013-09-04 | 桑迪士克科技股份有限公司 | 具有位于存储元件之间的可单独控制的屏蔽板的非易失性存储装置 |
| US7951814B2 (en) | 2008-06-17 | 2011-05-31 | Glenmark Pharmaceuticals, S.A. | Quinazolinedione derivatives as TRPA1 modulators |
| WO2009158719A2 (en) | 2008-06-27 | 2009-12-30 | Hydra Biosciences, Inc. | Methods and compositions for treating disorders |
| UA103918C2 (en) | 2009-03-02 | 2013-12-10 | Айерем Элелси | N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators |
| PE20120834A1 (es) | 2009-03-23 | 2012-07-25 | Glenmark Pharmaceuticals Sa | Derivados de furopirimidindiona como moduladores de trpa1 |
| BRPI1009372A2 (pt) | 2009-03-23 | 2016-05-31 | Glenmark Pharmaceuticals Sa | compostos, composição farmacêutica e respectivos usos |
| US8623880B2 (en) | 2009-03-23 | 2014-01-07 | Glenmark Pharmaceuticals S.A. | Fused pyrimidine-dione derivatives as TRPA1 modulators |
| AR076332A1 (es) | 2009-04-21 | 2011-06-01 | Boehringer Ingelheim Int | Derivados heterociclicos de 5-alquinil-piridinas, composiciones farmaceuticas que los comprenden y uso de los mismos para el tratamiento y/o prevencion del cancer, procesos inflamatorios, autoinmunes, y/o infecciones. |
| AU2010308028A1 (en) | 2009-10-15 | 2012-04-19 | Pfizer Inc. | Pyrrolo[2,3-d] pyrimidine compounds |
| AR078522A1 (es) | 2009-10-15 | 2011-11-16 | Lilly Co Eli | Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis |
| US8440710B2 (en) | 2009-10-15 | 2013-05-14 | Hoffmann-La Roche Inc. | HSL inhibitors useful in the treatment of diabetes |
| US8377980B2 (en) | 2009-12-16 | 2013-02-19 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| CN102812022B (zh) | 2010-01-12 | 2016-02-03 | Ab科学有限公司 | 噻唑和噁唑激酶抑制剂 |
| CN102666507B (zh) | 2010-07-13 | 2014-09-17 | 诺华股份有限公司 | 噁嗪衍生物及其在治疗神经病症中的用途 |
-
2010
- 2010-03-22 PE PE2011001704A patent/PE20120834A1/es not_active Application Discontinuation
- 2010-03-22 BR BRPI1013705A patent/BRPI1013705A2/pt not_active IP Right Cessation
- 2010-03-22 SG SG2011066446A patent/SG174398A1/en unknown
- 2010-03-22 WO PCT/IB2010/000840 patent/WO2010109329A1/en not_active Ceased
- 2010-03-22 SG SG2012069472A patent/SG184767A1/en unknown
- 2010-03-22 DK DK10716050.9T patent/DK2411395T3/da active
- 2010-03-22 JP JP2012501412A patent/JP2012521406A/ja active Pending
- 2010-03-22 EA EA201190138A patent/EA201190138A1/ru unknown
- 2010-03-22 US US13/257,280 patent/US20120178766A1/en not_active Abandoned
- 2010-03-22 SI SI201030233T patent/SI2411395T1/sl unknown
- 2010-03-22 CN CN2010800134701A patent/CN102361874A/zh active Pending
- 2010-03-22 PT PT107160509T patent/PT2411395E/pt unknown
- 2010-03-22 ES ES10716050T patent/ES2424341T3/es active Active
- 2010-03-22 KR KR1020117022604A patent/KR20110128898A/ko not_active Withdrawn
- 2010-03-22 PL PL10716050T patent/PL2411395T3/pl unknown
- 2010-03-22 CA CA2756535A patent/CA2756535A1/en not_active Abandoned
- 2010-03-22 AU AU2010227225A patent/AU2010227225A1/en not_active Abandoned
- 2010-03-22 EP EP10716050.9A patent/EP2411395B1/en not_active Not-in-force
- 2010-03-23 MX MX2011009822A patent/MX2011009822A/es unknown
- 2010-03-23 PL PL13002731T patent/PL2634191T3/pl unknown
- 2010-03-23 SG SG2012069530A patent/SG184769A1/en unknown
- 2010-03-23 SG SG2011066503A patent/SG174404A1/en unknown
- 2010-03-23 DK DK10751712.0T patent/DK2411396T3/da active
- 2010-03-23 DK DK13002731T patent/DK2634191T3/en active
- 2010-03-23 AP AP2011005889A patent/AP2948A/xx active
- 2010-03-23 JP JP2012501414A patent/JP5612070B2/ja not_active Expired - Fee Related
- 2010-03-23 PT PT13002731T patent/PT2634191E/pt unknown
- 2010-03-23 BR BRPI1009381A patent/BRPI1009381B8/pt active IP Right Grant
- 2010-03-23 EA EA201190139A patent/EA022029B1/ru unknown
- 2010-03-23 SI SI201030891T patent/SI2634191T1/sl unknown
- 2010-03-23 CN CN201310628814.5A patent/CN103755720B/zh not_active Expired - Fee Related
- 2010-03-23 SI SI201030231T patent/SI2411396T1/sl unknown
- 2010-03-23 WO PCT/IB2010/000930 patent/WO2010109334A2/en not_active Ceased
- 2010-03-23 AU AU2010227230A patent/AU2010227230B2/en not_active Ceased
- 2010-03-23 ES ES13002731.1T patent/ES2532386T3/es active Active
- 2010-03-23 EP EP13002731.1A patent/EP2634191B1/en active Active
- 2010-03-23 EP EP10751712.0A patent/EP2411396B1/en active Active
- 2010-03-23 KR KR1020117022603A patent/KR101524337B1/ko not_active Expired - Fee Related
- 2010-03-23 CN CN201080013463.1A patent/CN102361877B/zh not_active Expired - Fee Related
- 2010-03-23 PE PE2011001705A patent/PE20120775A1/es active IP Right Grant
- 2010-03-23 HU HUE13002731A patent/HUE024538T2/hu unknown
- 2010-03-23 PL PL10751712T patent/PL2411396T3/pl unknown
- 2010-03-23 ES ES10751712T patent/ES2424342T3/es active Active
- 2010-03-23 US US12/936,451 patent/US8507503B2/en not_active Expired - Fee Related
- 2010-03-23 CA CA2756536A patent/CA2756536C/en active Active
- 2010-03-23 PT PT107517120T patent/PT2411396E/pt unknown
-
2011
- 2011-09-15 IL IL215177A patent/IL215177A/en not_active IP Right Cessation
- 2011-09-15 IL IL215175A patent/IL215175A/en active IP Right Grant
- 2011-10-19 ZA ZA2011/07650A patent/ZA201107650B/en unknown
- 2011-10-19 ZA ZA2011/07649A patent/ZA201107649B/en unknown
-
2013
- 2013-06-25 US US13/925,975 patent/US8987278B2/en active Active
-
2015
- 2015-02-12 US US14/620,721 patent/US9474758B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018202568B2 (en) | Heterocyclyl compounds as MEK inhibitors | |
| CA2721695C (en) | Method for manufacturing aryl carboxamides | |
| RU2301804C2 (ru) | Производные тиазола, имеющие антагонистическую, агонистическую или частично агонистическую св1-активность | |
| JP2012521405A5 (enExample) | ||
| WO2020261114A1 (en) | 2,3-dihydroquinazolin compounds as nav1.8 inhibitors | |
| TWI697495B (zh) | 科帕利普（ｃｏｐａｎｌｉｓｉｂ）及其二鹽酸鹽之合成 | |
| JP2012521401A5 (enExample) | ||
| CA2230894A1 (en) | Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions | |
| JP2010513283A5 (enExample) | ||
| JP6523334B2 (ja) | 置換サイクロセリンの調製のための方法 | |
| JP2013521301A5 (enExample) | ||
| JP2023553291A (ja) | Ｔｒｐｍ３媒介性障害を治療するためのアリール誘導体 | |
| MX2011009822A (es) | Derivados de tienopirimidinadiona como moduladores del trpa1. | |
| TW201625633A (zh) | 科帕利普（ｃｏｐａｎｌｉｓｉｂ）及其二鹽酸鹽之合成 | |
| JP2008539183A (ja) | オキサゾールおよびチアゾール化合物ならびにｐｇｅ２介在障害の治療におけるそれらの使用 | |
| WO2005035496A1 (en) | Process for the preparation of n-amino substituted heterocyclic compounds | |
| CN119403794A (zh) | 用于治疗trpm3介导的病症的新型衍生物 | |
| TWI284127B (en) | Cyclization process for substituted benzothiazole derivatives | |
| WO2001064683A1 (en) | Processes for the production of thienopyrimidine derivatives | |
| JP2017119628A (ja) | 置換アゾール化合物及び糖尿病治療薬 | |
| Fujisaki et al. | A synthetic application of β-aminoalanines to some new 5-dialkylaminomethyl-3-phenylhydantoin derivatives | |
| Şener et al. | Synthesis and some reactions of 4‐(ethoxycarbonyl)‐1, 5‐diphenyl‐1H‐pyrazole‐3‐carboxylic acid | |
| KR101226332B1 (ko) | 2-(2-ｎ-부틸-4-히드록시-6-메틸-피리미딘-5-일)-Ｎ,Ｎ-디메틸아세트아미드의 신규한 제조방법 | |
| US10738012B2 (en) | Process for the preparation of amino-pyrazoles | |
| Ohta et al. | An Efficient and Practical Method for the Synthesis of the 5-Acylamino-4-(4-pyrimidinyl) isoxazole Derivative AKP-001, a Potent P38 MAP Kinase Inhibitor |